课题基金 / 基金详情

Defining the contribution of A-to-I RNA editing by ADAR’s in physiology and disease

Defining the contribution of A-to-I RNA editing by ADAR’s in physiology and disease
定义 ADAR 的 A 到 I RNA 编辑在生理学和疾病中的贡献
批准号:
nhmrc : GNT1144049
负责人:
A/Pr Carl Walkley
金额:
$72.82万
依托单位:
依托单位国家:
澳大利亚
项目类别:
Project Grants
财政年份:
2018
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2018-01-01 至 --

项目摘要

项目成果

A/Pr Carl Walkley的其他基金

相似基金

相关文献

中文摘要
翻译
我们正在努力了解一种名为ADAR的蛋白质家族是如何工作的。Adar蛋白可以改变细胞RNA的序列。当它们发生突变或在细胞中表达的量超过正常水平时,它们似乎会导致一系列人类疾病。我们正试图确定ADAR蛋白水平或活性的变化可能如何导致疾病。
英文摘要
We are working on understanding how a family of proteins called ADARs work. ADAR proteins can change the sequence of the cells RNA. When they are mutated or more than normal amounts are expressed in a cell it appears they can cause a range of diseases in humans. We are trying to determine how changes in the level or activity of ADAR proteins may contribute to disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Defining the contribution of A-to-I RNA editing by ADAR’s in physiology and disease
Understanding the function of Recql4 in DNA replication and genome maintenance
  • 批准号:
    nhmrc : GNT1126004
  • 项目类别:
    Project Grants
  • 资助金额:
    $69.84万
  • 财政年份:
    2017
  • 负责人:
    A/Pr Carl Walkley
  • 依托单位:
Microenvironmental regulation of blood cells by retinoic acid receptor gamma.
Microenvironmental regulation of blood cells by retinoic acid receptor gamma.
  • 批准号:
    nhmrc : GNT1127551
  • 项目类别:
    Project Grants
  • 资助金额:
    $95.84万
  • 财政年份:
    2017
  • 负责人:
    A/Pr Carl Walkley
  • 依托单位:
海外基金